What type of study is this?

This is a Observational study (also classified as: Case Report).

August 21, 2025MedicineOpen Access

Comparing the effectiveness of treating branch retinal vein occlusion with a novel one and stepped pro re nata treatment protocol

View Full Paper

Ask AI

Bookmark

Authors

PCPo‐Yu ChenChina Medical University AHAlan Y. HsuChina Medical University CLChun‐Ting LaiAsia University

Discussion

Member takes

Implication

Retrospective analysis shows improvement in visual acuity and retinal thickness in BRVO patients treated with a novel anti-VEGF protocol, suggesting its efficacy.

Key Points

Average best corrected visual acuity improved by about 23.9 letters, indicating significant enhancement in eye health.
Treatments involved anti-VEGF agents, with 68.2% of patients receiving Aflibercept and 31.8% Ranibizumab during the study period.
Observational analysis over 54 weeks highlighted effective outcomes with fewer anti-VEGF injections compared to previous trials.
Findings support the use of the novel treatment approach in the management of branch retinal vein occlusion.

Cite This Study

Chen et al. (2025) studied this question.

synapsesocial.com/papers/68a6fb925502675167ba8fdc https://doi.org/10.1097/md.0000000000043931

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis shows improvement in visual acuity and retinal thickness in BRVO patients treated with a novel anti-VEGF protocol, suggesting its efficacy.

Comparing the effectiveness of treating branch retinal vein occlusion with a novel one and stepped pro re nata treatment protocol

Discussion

Member takes

Implication

Key Points

Cite This Study

Comparing the effectiveness of treating branch retinal vein occlusion with a novel one and stepped pro re nata treatment protocol

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider